Survivors | Nonsurvivors | P | |||
---|---|---|---|---|---|
Median | (IQR) | Median | (IQR) | ||
Onset of hyperglycemia, h | 6.5 | (3.7 -27) | 59 | (13.5-137.5) | .028 |
Baseline cortisol, μg/dL | 37 | (12.4-66) | 100 | (74–138) | .024 |
Cortisol at 24 h, μg/dL | 13 | (5.6 -22.4) | 39.7 | (29.9-59.3) | .003 |
Baseline GH, μg/dL | 0.7 | (0.5-3.6) | 15 | (1.8-31) | .026 |
Sensitivity with C-peptide at 72 h, % | 29.0 | (14.3-67.8) | 11.9 | (10.7-12.9) | .026 |
IR with C-peptide at 72 h | 3.4 | (1.5-6.9) | 8.4 | (7.7 -9.3) | .026 |
Cardiogenic shock | 7.3% | 60% | .014 | ||
Nosocomial infection | 30.7% | 100% | .008 | ||
ECMO | 0% | 100% | .001 | ||
CRRT | 0% | 100% | .001 |